Clinical trials of new vaccines protivotuberkuleznoe conducted by Russian scientists. Portal "Remedium" reports that by the end of this year the development of this vaccine can be completed.
According to first Deputy head of the Ministry of health Tatiana Yakovleva, the vaccine has already shown its effectiveness in the early stages of the study. Verification is carried out by specialists of the National research centre of epidemiology and Microbiology them. N. F. Gamalei.
The official also said that this year may be completed the second phase of clinical trials. In the case of its successful passage, a vaccine will be available to the doctors, but to use it only for adults.
In accordance with the statistical information of the world health organization, every year of tuberculosis 10 million people, but because anti-TB the vaccine could become a major medical achievement. So, in Rospotrebnadzor note that only during the 2018 fixed over 61 thousand patients with tuberculosis, which is 7.7% below the previous year. The reason for this, not least is vaccination.